|
 |
 |
Stephen Hanauer, MD
Professor of Medicine
and
Clinical Pharmacology
Chief, Section of Gastroenterology
and Nutrition
University of Chicago Hospitals
Chicago, Illinois |
|
|
New Biologics in the Treatment of Crohn's Disease —William Sandborn, MD, Executive Editor |
| Part 1: |
Advances In Treatment with New Biologics
—Stephen Hanauer, MD
- for reference only, not for CME credit
|
Download PDF |
| Part 2: |
New Targets for Disease Modification: Anti-Alpha4 Integrin Therapy —William Sandborn, MD
- for reference only, not for CME credit
|
Download
PDF |
| Part 3: |
Maximizing Outcomes in Crohn's Disease —Brian Feagan, MD - for reference only, not for CME credit |
Download
PDF |
 |
Redefining Treatment in Ulcerative Colitis
—William Sandborn, MD, Executive Editor |
Part 1:
|
Making Sense of Multiple Options: The 5-ASAs
— William J. Sandborn, MD, and Douglas C.Wolf, MD
- for reference only, not for CME credit
|
Download PDF |
Part 2:
|
Pharmacodynamics and Pharmacokinetics of 5-ASA Formulations
— William J. Sandborn, MD, Stephen B. Hanauer, MD, & Charles A. Sninsky, MD
- for reference only, not for CME credit
|
Download PDF |
Part 3:
|
Examining the Ulcerative Colitis–Colorectal Cancer Link
—William J. Sandborn, MD, Thomas A. Ullman, MD, and Fernando S. Velayos, MPH
- for reference only, not for CME credit
|
Download PDF |
Part 4:
|
Individualizing Treatment —William J. Sandborn, MD,Uma Mahadevan-Velayos, MD, and Edward V. Loftus Jr, MD
|
Download PDF |
|
| |
|
|